Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant

Standard

Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant : a center's experience. / Sotiropoulos, G C; Lang, H; Saner, F H; Beckebaum, S; Wandelt, M; Molmenti, E P; Nadalin, S; Treckmann, J; Bockhorn, M; Fouzas, I; Malagó, M; Gerken, G; Broelsch, C E; Paul, A.

in: TRANSPL P, Jahrgang 40, Nr. 9, 01.11.2008, S. 3196-7.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Sotiropoulos, GC, Lang, H, Saner, FH, Beckebaum, S, Wandelt, M, Molmenti, EP, Nadalin, S, Treckmann, J, Bockhorn, M, Fouzas, I, Malagó, M, Gerken, G, Broelsch, CE & Paul, A 2008, 'Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experience', TRANSPL P, Jg. 40, Nr. 9, S. 3196-7. https://doi.org/10.1016/j.transproceed.2008.08.055

APA

Sotiropoulos, G. C., Lang, H., Saner, F. H., Beckebaum, S., Wandelt, M., Molmenti, E. P., Nadalin, S., Treckmann, J., Bockhorn, M., Fouzas, I., Malagó, M., Gerken, G., Broelsch, C. E., & Paul, A. (2008). Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experience. TRANSPL P, 40(9), 3196-7. https://doi.org/10.1016/j.transproceed.2008.08.055

Vancouver

Bibtex

@article{9ab403a8907744898eb497f57c19698e,
title = "Long-term results after liver transplantation with {"}livers that nobody wants{"} within Eurotransplant: a center's experience",
abstract = "BACKGROUND: Orthotopic liver transplantation (OLT) represents the only curative treatment for end-stage liver disease, but its application is limited because of organ shortages. The purpose of this study was to review the long-term outcomes after OLT during a 2-year period of 45 rescue offers organs within Eurotransplant.PATIENTS AND METHODS: Forty-five deceased donor liver allografts had been officially offered to and rejected by other transplantation centers 162 times prior to our acceptance. Data analysis addressed recurrence of primary disease, ischemic-type biliary lesions (ITBL), re-evaluation or relisting for OLT, re-OLT, as well as overall patient and graft survivals.RESULTS: Six patients underwent retransplantation because of primary nonfunction (n = 4), hepatitis C recurrence (n = 1), and secondary biliary cirrhosis following ITBL (n = 1). Five additional patients developed ITBL and received endoscopic treatment. Currently, 34 patients are alive after a median follow-up of 44.5 months. Median graft survival is 43.2 months. Patient versus patient/first graft survival at 1, 3, and 5 years is 82%, 78%, and 74%, versus 76%, 69%, and 65%, respectively.CONCLUSIONS: OLT with rescue organs is a reasonable policy, with acceptable long-term patient/graft survivals, providing a real expansion of the donor pool.",
keywords = "Adult, Cadaver, Female, Graft Survival, Humans, Liver Failure, Liver Transplantation, Male, Middle Aged, Patient Selection, Reoperation, Survival Rate, Survivors, Tissue Donors, Transplantation, Homologous, Treatment Outcome",
author = "Sotiropoulos, {G C} and H Lang and Saner, {F H} and S Beckebaum and M Wandelt and Molmenti, {E P} and S Nadalin and J Treckmann and M Bockhorn and I Fouzas and M Malag{\'o} and G Gerken and Broelsch, {C E} and A Paul",
year = "2008",
month = nov,
day = "1",
doi = "10.1016/j.transproceed.2008.08.055",
language = "English",
volume = "40",
pages = "3196--7",
journal = "TRANSPL P",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "9",

}

RIS

TY - JOUR

T1 - Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant

T2 - a center's experience

AU - Sotiropoulos, G C

AU - Lang, H

AU - Saner, F H

AU - Beckebaum, S

AU - Wandelt, M

AU - Molmenti, E P

AU - Nadalin, S

AU - Treckmann, J

AU - Bockhorn, M

AU - Fouzas, I

AU - Malagó, M

AU - Gerken, G

AU - Broelsch, C E

AU - Paul, A

PY - 2008/11/1

Y1 - 2008/11/1

N2 - BACKGROUND: Orthotopic liver transplantation (OLT) represents the only curative treatment for end-stage liver disease, but its application is limited because of organ shortages. The purpose of this study was to review the long-term outcomes after OLT during a 2-year period of 45 rescue offers organs within Eurotransplant.PATIENTS AND METHODS: Forty-five deceased donor liver allografts had been officially offered to and rejected by other transplantation centers 162 times prior to our acceptance. Data analysis addressed recurrence of primary disease, ischemic-type biliary lesions (ITBL), re-evaluation or relisting for OLT, re-OLT, as well as overall patient and graft survivals.RESULTS: Six patients underwent retransplantation because of primary nonfunction (n = 4), hepatitis C recurrence (n = 1), and secondary biliary cirrhosis following ITBL (n = 1). Five additional patients developed ITBL and received endoscopic treatment. Currently, 34 patients are alive after a median follow-up of 44.5 months. Median graft survival is 43.2 months. Patient versus patient/first graft survival at 1, 3, and 5 years is 82%, 78%, and 74%, versus 76%, 69%, and 65%, respectively.CONCLUSIONS: OLT with rescue organs is a reasonable policy, with acceptable long-term patient/graft survivals, providing a real expansion of the donor pool.

AB - BACKGROUND: Orthotopic liver transplantation (OLT) represents the only curative treatment for end-stage liver disease, but its application is limited because of organ shortages. The purpose of this study was to review the long-term outcomes after OLT during a 2-year period of 45 rescue offers organs within Eurotransplant.PATIENTS AND METHODS: Forty-five deceased donor liver allografts had been officially offered to and rejected by other transplantation centers 162 times prior to our acceptance. Data analysis addressed recurrence of primary disease, ischemic-type biliary lesions (ITBL), re-evaluation or relisting for OLT, re-OLT, as well as overall patient and graft survivals.RESULTS: Six patients underwent retransplantation because of primary nonfunction (n = 4), hepatitis C recurrence (n = 1), and secondary biliary cirrhosis following ITBL (n = 1). Five additional patients developed ITBL and received endoscopic treatment. Currently, 34 patients are alive after a median follow-up of 44.5 months. Median graft survival is 43.2 months. Patient versus patient/first graft survival at 1, 3, and 5 years is 82%, 78%, and 74%, versus 76%, 69%, and 65%, respectively.CONCLUSIONS: OLT with rescue organs is a reasonable policy, with acceptable long-term patient/graft survivals, providing a real expansion of the donor pool.

KW - Adult

KW - Cadaver

KW - Female

KW - Graft Survival

KW - Humans

KW - Liver Failure

KW - Liver Transplantation

KW - Male

KW - Middle Aged

KW - Patient Selection

KW - Reoperation

KW - Survival Rate

KW - Survivors

KW - Tissue Donors

KW - Transplantation, Homologous

KW - Treatment Outcome

U2 - 10.1016/j.transproceed.2008.08.055

DO - 10.1016/j.transproceed.2008.08.055

M3 - SCORING: Journal article

C2 - 19010232

VL - 40

SP - 3196

EP - 3197

JO - TRANSPL P

JF - TRANSPL P

SN - 0041-1345

IS - 9

ER -